COMMUNIQUÉS West-GlobeNewswire

AXIM® Biotechnologies, Inc. Appoints Mauricio Javier Gatto-Bellora to Company’s Board of Directors
04/04/2019
NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today announced the appointment of [...]
Tauriga Sciences Inc. Showcases its Graphic Design and Artwork for the Retail Display Boxes of its Two Newest Tauri-Gum Flavors: Blood Orange & Pomegranate
04/04/2019
New York, NY, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
iCAD to Highlight ProFound AI™ Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium
04/04/2019
Company’s Latest, Deep-Learning, Cancer Detection Software Solution Recently Launched in U.S. NASHUA, N.H., April 04, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
Changes to the Management Board of JSC Olainfarm and Representation Rights
04/04/2019
JSC Olainfarm hereby informs about the following decisions taken by its Supervisory Council on April 04, 2019: Recall Olegs Grigorjevs, Mihails Raizbergs, Vladimirs Krušinskis from the position of the Management Board [...]
Terveystalo Plc: Resolutions of the Organizing Meeting of Board of Directors
04/04/2019
Terveystalo Plc, Stock Exchange Release 4 April 2019 at 17:25 EEST At its organizing meeting held after the Annual General Meeting held today, the Board of Directors of Terveystalo Plc made the following resolutions: [...]
Terveystalo Plc: Resolutions of Annual General Meeting
04/04/2019
Terveystalo Plc, Stock Exchange Release 4 April 2019 at 17:15 EEST The Annual General Meeting of Terveystalo Plc was held today on 4 April 2019 in Helsinki, Finland. The Annual General Meeting adopted the financial [...]
eSolutions Inc. Achieves HITRUST CSF® Certification and HITRUST Certification of the NIST Cybersecurity Framework to Manage Risk, Improve Security Posture and Meet Compliance Requirements
04/04/2019
HITRUST CSF Certification and HITRUST Certification of the NIST Cybersecurity Framework validates eSolutions Inc. is committed to meeting key regulations and protecting sensitive information OVERLAND PARK, Kan., April [...]
ENLIVEX THERAPEUTICS TO PRESENT AT THE 2019 H.C. WAINWRIGHT GLOBAL LIFE SCIENCES CONFERENCE
04/04/2019
Nes-Ziona, Israel, April 04, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced that company management will make a corporate presentation at the H. [...]
Pluristem Therapeutics Inc. Announces Pricing of Its Public Offering and Registered Direct Offering for Aggregate Proceeds of Approximately $20 Million
04/04/2019
HAIFA, Isreal, April 04, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PLTR) (“Pluristem” or “Company”), a leading regenerative medicine company developing novel placenta-based cell therapy [...]
ATW Tech Announces Revenue Growth of 13% for 2018 to Reach $12.0m
04/04/2019
MONTREAL, April 04, 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the “Company”) (TSX-V: ATW) announces its annual financial results for the year ended December 31, 2018. The Company generated year-over-year revenue growth of [...]
ATW Tech annonce des revenus en croissance de 13% en 2018 pour atteindre 12m$
04/04/2019
MONTRÉAL, 04 avr. 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société ») (TSX-V : ATW) annonce aujourd'hui ses résultats pour son exercice terminé le 31 décembre 2018. Pour 2018, la Société a généré une croissance des [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.1%
04/04/2019
BUENA, N.J., April 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity
04/04/2019
Accretive acquisition of Colorado-based clinic group bolsters Company’s US medical cannabis clinical roll-up strategy; adds 15,000 new patients TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “ [...]
Paratek Pharmaceuticals Presenting New Data from NUZYRA™ (Omadacycline) Development Program at ECCMID 2019
04/04/2019
Data Highlight Paratek’s Commitment to Further Understanding Omadacycline’s Utility in Life-Threatening Infections such as CABP and ABSSSI BOSTON, April 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq [...]
SELLAS Life Sciences Group and World-Renowned Cancer Center to Study Galinpepimut-S (GPS) in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma (MPM)
04/04/2019
Initiation of Phase 1 Clinical Trial in Relapsed or Refractory MPM Expected in the Second Quarter of 2019 Previous Combination Study of GPS and Nivolumab Given After Salvage Chemotherapy in Ovarian Cancer Patients [...]
PSIQ Reports Record Breaking Annual Revenues of $ 876,448 for 2018 as Compared to $ 208,236 for 2017, an Increase of Over 400% and Poised for Rapid Expansion in 2019
04/04/2019
SUNRISE, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), reported Revenues for the year [...]
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
04/04/2019
Ongoing Phase 1/2 study of ABO-101 enrolling eligible patients with MPS IIIB NEW YORK and CLEVELAND, April 04, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene [...]
Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board
04/04/2019
EMERYVILLE, Calif., April 04, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Aptinyx to Present at 18th Annual Needham Healthcare Conference
04/04/2019
EVANSTON, Ill., April 04, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]

Pages